Tag Archives: hypertension
November 2006 Br J Cardiol 2006;13:434-40
The effectiveness and tolerability of lercanidipine is independent of body mass index or body fat percent. The LERZAMIG study
Vivencio Barrios, Carlos Escobar, Alberto Calderón, Angel Navarro, Luis M Ruilope
No content available
November 2005 Br J Cardiol 2005;12:471-6
Hypertension – its detection, prevalence, control and treatment in a quality driven British general practice
Peter Standing, Helen Deakin, Paul Norman, Ruth Standing
No content available
March 2005 Br J Cardiol 2005;12:125-9
A review of olmesartan medoxomil – a new angiotensin II receptor blocker
Andrew Whittaker
No content available
March 2005 Br J Cardiol 2005;12:107-16
The management of hypertension in patients with benign prostatic hyperplasia and erectile dysfunction
Michael Kirby, Roger Kirby
(more…)
January 2005 Br J Cardiol 2005;12:65-70
Evidence-based treatment of hypertension: what’s the role of angiotensin II receptor blockers?
FD Richard Hobbs, Peter Irwin, Janet Rubner
No content available
January 2005 Br J Cardiol 2005;12:31-6
The role of candesartan in the treatment of chronic heart failure
Hugh F McIntyre
No content available
September 2004 Br J Cardiol 2004;11:379-86
Cocoa, flavanols and cardiovascular risk
Norman K Hollenberg, Harold Schmitz, Ian MacDonald, Neil Poulter
No content available
July 2004 Br J Cardiol 2004;11:315-20
Angiotensin II receptor blockers: a new lease of LIFE?
Michael Kirby, Rubin Minhas
No content available
July 2004 Br J Cardiol 2004;11:292-9
Hypercholesterolaemia and its potential role in the presentation and exacerbation of hypertension
Andrei C Sposito, Jose Augusto S Barreto-Filho
No content available
July 2004 Br J Cardiol 2004;11:282-6
The National Cholesterol Education Program III scoring system for CHD risk estimation cannot be used with European recommendations
Navneet Singh, See Kwok, C Jeffrey Seneviratne, Michael France, Paul Durrington
No content available
For healthcare professionals only
